Chemical Compound

Lincomycin hydrochloride

CAS Registry Number 859-18-7
Lincomycin hydrochloride chemical structure
Primary Record

Lincomycin hydrochloride

In stock
1,025 g
Purity
98.8 %
CAS
859-18-7

Compound Identifiers & Properties

CAS
859-18-7
PubChem CID
64710
SMILES
CCC[C@@H]1C[C@H](N(C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@@H](C)O.Cl
Canonical SMILES
CCC[C@@H]1C[C@@H](C(=O)N[C@@H]([C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)[C@@H](C)O)N(C)C1.Cl

Names & Synonyms

  • Lincomycin hydrochloride
  • LINCOMYCIN HCL
  • Frademicina
  • Lincocin
  • Lincomix
  • lincomycin
  • Lincogap
  • Mycivin
  • Lincomix 20
  • Lincomycin soluble
  • 859-18-7
  • Linco Soluble
  • LinxMed-SP
  • Lincocin Hydrochloride
  • Lincomix 50
  • Pura Ject 100
  • lincomycin HCl salt
  • LincoBac 300
  • LincoMed 100
  • Lincolnensin hydrochloride
  • Lincomycin (hydrochloride)
  • Lincomycin hydrochloride anhydrous
  • Lincosol Soluble Powder
  • Lincolnensin, hydrochloride
  • Lincomycin HCl (Lincocin)
  • Lincomycin hydrochloride monohydrate
  • RefChem:582700
  • C18H35ClN2O6S
  • GCW8Y9936L
  • LINCOMIX Soluble Powder
  • UNII-GCW8Y9936L
  • C18H34N2O6S.HCl
  • LINCOMYCIN 300
  • DTXSID7047803
  • Lincomycin hydrochloride usp
  • Lincomycin Monohydrochloride
  • AC1L21SE
  • Lincomycin hydrochloride CRS
  • Antibiotic 124a, hydrochloride
  • MFCD00083647
  • C18H34N2O6S.ClH
  • DTXCID9027780
  • Lincomycin (as hydrochloride)
  • SCHEMBL192964
  • UNII-M6T05Z2B68
  • POUMFISTNHIPTI-BOMBIWCESA-N
  • CCRIS 9080
  • MSK7802A
  • orb1309148
  • Lincomycin hydrochloride anhdrous
  • CTK8B3221
  • EINECS 212-726-7
  • ERK5-1P21
  • HY-B0417A
  • LincoMed 100, LincoMed 300
  • Lincomycin, hydrochloride hydrate
  • C18H34N2O6S.ClH.H2O
  • NSC 70731
  • U 10149a
  • Lincomycin (hydrochloride hydrate)
  • M6T05Z2B68
  • MSK7802A-100M
  • CID64710
  • NSC70731
  • Lincomycin hydrochloride [USP:JAN]
  • MSK7802A-1000M
  • Tox21_111575
  • ANW-42016
  • BBF-02653
  • EBC-11104
  • Lincolnensin hydrochloride monohydrate
  • Lincomycin hydrochloride [USAN:JAN]
  • MFCD22631533
  • NCGC00159326-02
  • NSC-70731
  • AKOS024375415
  • C18-H34-N2-O6-S.Cl-H
  • Tox21_111575_1
  • AL16775
  • CCG-220302
  • CS-2521
  • Lincomycin Hydrochloride Soluble Powder
  • NSC-757092
  • 7179-49-9
  • ANHYDROUS LINCOMYCIN HYDROCHLORIDE
  • LINCOMYCIN HYDROCHLORIDE [WHO-DD]
  • NCGC00159326-03
  • AN-15758
  • AN-20542
  • AS-13720
  • CAS-859-18-7
  • H021
  • Lincomycin hydrochloride, >=90% (TLC)
  • SY006929
  • EC 212-726-7
  • C18-H34-N2-O6-S.Cl-H.H2-O
  • Lincomycin hydrochloride, >=95.0% (TLC)
  • LS-174366
  • TR-031563
  • FT-0658935
  • L0166
  • NS00076397
  • ST51016093
  • LINCOMYCIN HYDROCHLORIDE ANHDROUS [MI]
  • Lincomycin hydrochloride for system suitability
  • A-7633
  • J10175
  • EN300-6494894
  • 859L187
  • A841491
  • ANHYDROUS LINCOMYCIN HYDROCHLORIDE [MART.]
  • Lincomycin hydrochloride for system suitability CRS
  • Q27279041
  • (2S,4R)-N-((1R,2R)-2-hydroxy-1-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylthio)tetrahydro-2H-pyran-2-yl)propyl)-1-methyl-4-propylpyrrolidine-2-carboxamide hydrochloride
  • Lincomycin hydrochloride Solution in Methanol, 100ug/mL
  • Lincomycin hydrochloride Solution in Methanol, 1000ug/mL
  • (2S,4R)-N-{(1S)-2-hydroxy-1-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylthio)-tetrahydro-2H-2-pyranyl]propyl}-1-methyl-4-propylpyrrolidine-2-carboxamide Hydrochloride
  • Lincomycin hydrochloride, BioReagent, suitable for cell culture
  • 7179-49-9, 859-18-7 [anhydrous], 154-21-2 [lincomycin]
  • (2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylsulfanyl)oxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide hydrochloride
  • (2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,5R,6R)-3,4,5-trihydroxy-6-(methylsulfanyl)oxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide hydrochloride
  • D-erythro-alpha-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, monohydrochloride, (2S-trans)-
  • Lincomycin hydrochloride, British Pharmacopoeia (BP) Reference Standard
  • (2s,4r)-N-[(1r,2r)-2-hydroxy-1-[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(methylsulfanyl)oxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboximidic acid hydrochloride
  • (2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyl-tetrahydropyran-2-yl]propyl]-1-methyl-4-propyl-pyrrolidine-2-carboxamide hydrochloride
  • (2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyl-tetrahydropyran-2-yl]propyl]-1-methyl-4-propyl-pyrrolidine-2-carboxamide;hydrochloride
  • (2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide hydrochloride
  • (2S,4R)-N-[(1R,2R)-2-Hydroxy-1-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylthio)-tetrahydro-2H-2-pyranyl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide Hydrochloride
  • (2S-TRANS)-METHYL 6,8-DIDEOXY-6-(((1-METHYL-4-PROPYL-2-PYRROLIDINYL)CARBONYL)AMINO)-1-THIO-D-ERYTHRO-.ALPHA.-D-GALACTO-OCTOPYRANOSIDE HYDROCHLORIDE
  • (2S-trans)-Methyl 6,8-Dideoxy-6-[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-thio-D-erythro-alpha-D-galactooctopyranoside Hydrochloride
  • 154-21-2
  • 212-726-7
  • D-eritro-alfa-D-galacto-Octopiranosido, metil 6,8-didesoxi-6-[[[(2S, 4R)-1-metil-4-propil-2-pirrolidinil] carbonil] amino]-1-tio-,clorhidrato de (1:1)
  • D-ERYTHRO-.ALPHA.-D-GALACTO-OCTOPYRANOSIDE, METHYL 6,8-DIDEOXY-6-(((1-METHYL-4-PROPYL-2-PYRROLIDINYL)CARBONYL)AMINO)-1-THIO-, MONOHYDROCHLORIDE, (2S-TRANS)-
  • D-erythro-.alpha.-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-thio-, monohydrochloride, (2S-trans)-
  • D-erythro-.alpha.-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-thio-, monohydrochloride, monohydrate, (2S-trans)-
  • D-erythro-.alpha.-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-, hydrochloride (1:1)
  • D-erythro-.alpha.-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-, monohydrochloride
  • D-erythro-?-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-[[(1-methyl- 4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-thio-, monohydrochloride, (2S-trans)-
  • D-erythro-|A-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-, hydrochloride (1:1)
  • D-erythro-alpha-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-((((2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, monohydrochloride
  • D-erythro-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-(1-methyl-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-, monohydrochloride, monohydrate,trans- .alpha.-
  • D-erythro-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-(1-methyl-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-, monohydrochloride, trans- .alpha.-
  • D-erythro-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-(1-methyl-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-, monohydrochloride, trans-alpha-
  • Lincomycin Hydrochloride; D-erythro-a-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-, hydrochloride (1:1); D-erythro-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-(1-methyl-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-, monohydrochloride, trans-a- (8CI); D-erythro-a-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-thio-, monohydrochloride, (2S-trans)-; D-erythro-a-D-galacto-Octopyranoside, methyl 6,8-dideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-, monohydrochloride (9CI); Lincomycin hydrochloride (7CI); Lincocin; Lincogap; Lincomix; NSC 70731; U 10149a; Clindamycin Hydrochloride Impurity A as Hydrochloride Monohydrate; Clindamycin Phosphate Impurity A as Hydrochloride Monohydrate; Clindamycin Impurity A as Hydrochloride Monohydrate
  • Methyl (2S-trans)-6,8-dideoxy-6-(((1-methyl-4-propylpyrrolidin-2-yl)carbonyl)amino)-1-thio-D-erythro-alpha-D-galacto-octopyranoside monohydrochloride
  • Methyl (2S-trans)-6,8-dideoxy-6-[[(1-methyl-4-propylpyrrolidin-2-yl)carbonyl]amino]-1-thio-D-erythro-alpha-D-galacto-octopyranoside monohydrochloride
  • methyl 6,8-dideoxy-6-(((4R)-1-methyl-4-propyl-L-prolyl)amino)-1-thio-D-erythro-alpha-D-galacto-octopyranoside hydrochloride anhydrous
  • Methyl 6,8-dideoxy-6-(1-methyl-4-propyl-2-pyrrolidinecarboxamido)-1-thio-D-erythro-|A-D-galactooctopyranoside hydrochloride
  • METHYL 6,8-DIDEOXY-6-(1-METHYL-TRANS-4-PROPYL-L-2-PYRROLIDINECARBOXAMIDO)-1-THIO-D-ERYTHRO-.ALPHA.-D-GALACTO-OCTOPYRANOSIDE MONOHYDROCHLORIDE
  • Methyl 6,8-dideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-D-erythro-alpha-D-galacto-octopyranoside monohydrochloride monohydrate
  • Methyl 6,8-dideoxy-6-{[(4R)-1-methyl-4-propyl-L-prolyl]amino}-1-thio-D-erythro-alpha-D-galacto-octopyranoside--hydrogen chloride (1/1)
  • N-[(1R,2R)-1-((4S,2R,3R,5R,6R)-3,4,5-trihydroxy-6-methylthio(2H-3,4,5,6-tetrah ydropyran-2-yl))-2-hydroxypropyl]((2S,4R)-1-methyl-4-propylpyrrolidin-2-yl)car boxamide, chloride